Samatasvir

Generic Name: Samatasvir

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₄₇H_₄₈N_₈O_₆S_₂

CAS Number: 1312547-19-5

Unique Ingredient Identifier: 21P699C5FC

Background: Samatasvir has been used in trials studying the treatment of Hepatitis C, Chronic, Chronic Hepatitis C Virus, and Chronic Hepatitis C Infection.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)

Phase 2

Completed

Conditions: Chronic Hepatitis C Virus

Interventions: Drug: Samatasvir
Drug: Simeprevir
Drug: Ribavirin (RBV)
Biological: Pegylated interferon (Peg-IFN)
Drug: TMC647055
Other: Samatasvir matching placebo
Drug: Ritonavir (RTV)

First Posted Date: 2013-05-14

Last Posted Date: 2015-04-23

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 143

Registration Number: NCT01852604

To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

Phase 1

Completed

Conditions: Chronic Hepatitis C Infection

Interventions: Drug: Samatasvir
Drug: Ritonavir
Drug: Omeprazole

First Posted Date: 2013-03-19

Last Posted Date: 2016-01-22

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 24

Registration Number: NCT01813552

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy